Home » Newsletters » BioWorld

BioWorld

Jan. 28, 1992

View Archived Issues

GYNEX TO USE VA DATA IN FDA REVIEW

CYTRX TO REDEEM CLASS B WARRANTS

UNIGENE PLANS CALCITONIN SALES

DNAP TO ACQUIRE JOINT VENTURE

YAMANOUCHI TO SELL ABS TEST KITS

STEM CELL CONCENTRATOR SUCCESSFUL IN TESTS

INSITE TO EYE SYNERGEN'S ANTRIL

CARRINGTON REPORTS PROFITABLE YEAR

BUSH TO DISCUSS BIOTECH INITIATIVE

AMYLIN RECEIVES FIRST PATENT NOTICE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...